Cyclization strategies in peptide derived drug design

Area of Science:

• Biochemistry and Medicinal Chemistry
• Drug Discovery and Development

Background:

• Peptides are natural biological molecules (hormones, growth factors) and protein building blocks.
• Natural and mutated peptides serve as pharmacophore models for drug development.
• Linear peptides often lack stability, limiting their therapeutic use.

Purpose of the Study:

• To review recent methodologies for designing and synthesizing cyclized peptides.
• To highlight the impact of cyclization on peptide stability and biological activity.
• To provide examples of cyclized peptides in drug development.

Main Methods:

• Peptidomimetic modification to create biostable peptide analogs.
• Cyclization of linear peptides to enhance conformational restriction and stability.
• Review of literature on peptide cyclization techniques and applications.

Main Results:

• Cyclization restricts peptide conformation, increasing resistance to degradation.
• Modified peptides demonstrate enhanced proteolytic stability compared to linear counterparts.
• Cyclized peptides show altered and often improved biological activity.

Conclusions:

• Cyclization is a key strategy for developing stable and potent peptide-based therapeutics.
• Recent advancements offer novel routes for designing and synthesizing cyclized peptides.
• Further research into cyclized peptides holds promise for future drug discovery.